(PCVX) Vaxcyte - Performance -45.2% in 12m
Compare PCVX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
30.85%
#19 in Group
Rel. Strength
12.96%
#6992 in Universe
Total Return 12m
-45.19%
#107 in Group
Total Return 5y
25.89%
#33 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -21.43%
(?) Percentile in Group
12m Total Return: PCVX (-45.2%) vs XBI (-2.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8% | 23.5% | 161% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
2.55% | 23.2% | 41.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-8.48% | 7.43% | 35.1% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
0.56% | 12.5% | 38.1% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-1.7% | 17.1% | 0.22% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-8.13% | -22.5% | 4.98% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-5.51% | 32.3% | -8.24% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
6.82% | -5.27% | 21% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: PCVX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PCVX
| Total Return (including Dividends) | PCVX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -54.21% | -7.84% | -4.31% |
| 3 Months | -63.79% | -13.34% | -7.85% |
| 12 Months | -45.19% | -2.25% | 10.76% |
| 5 Years | 25.89% | -18.04% | 106.31% |
| Trend Score (consistency of price movement) | PCVX | XBI | S&P 500 |
| 1 Month | -30.8% | -17.6% | -35.6% |
| 3 Months | -93.2% | -91.9% | -89.7% |
| 12 Months | 3.80% | -36.5% | 58.3% |
| 5 Years | 74.4% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #198 | -50.3% | -52.2% |
| 3 Month | #192 | -58.2% | -60.7% |
| 12 Month | #107 | -43.9% | -50.5% |
| 5 Years | #33 | 56.6% | -35.3% |
FAQs
Does PCVX Vaxcyte outperforms the market?
No,
over the last 12 months PCVX made -45.19%, while its related Sector, the SPDR S&P Biotech (XBI) made -2.25%.
Over the last 3 months PCVX made -63.79%, while XBI made -13.34%.
Over the last 3 months PCVX made -63.79%, while XBI made -13.34%.
Performance Comparison PCVX vs Indeces and Sectors
PCVX vs. Indices PCVX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.18% | -49.9% | -66.6% | -56.0% |
| US NASDAQ 100 | QQQ | -0.78% | -50.0% | -66.6% | -57.2% |
| US Dow Jones Industrial 30 | DIA | 3.25% | -48.4% | -66.8% | -52.2% |
| German DAX 40 | DAX | 3.84% | -50.4% | -85.0% | -68.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.71% | -50.7% | -65.1% | -53.8% |
| Hongkong Hang Seng | HSI | 3.45% | -51.3% | -68.4% | -59.2% |
| India NIFTY 50 | INDA | 8.61% | -55.8% | -68.2% | -47.0% |
| Brasil Bovespa | EWZ | 1.43% | -56.2% | -71.1% | -39.7% |
PCVX vs. Sectors PCVX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.32% | -48.6% | -75.3% | -67.6% |
| Consumer Discretionary | XLY | -1.17% | -50.2% | -69.7% | -59.5% |
| Consumer Staples | XLP | 8.64% | -57.0% | -71.9% | -54.7% |
| Energy | XLE | 4.53% | -42.6% | -64.1% | -33.3% |
| Financial | XLF | 3.14% | -49.4% | -74.7% | -64.5% |
| Health Care | XLV | 4.20% | -49.2% | -64.5% | -45.5% |
| Industrial | XLI | 3.01% | -50.1% | -66.9% | -52.1% |
| Materials | XLB | 4.43% | -49.7% | -59.7% | -39.9% |
| Real Estate | XLRE | 6.01% | -52.3% | -64.4% | -60.3% |
| Technology | XLK | -2.63% | -49.7% | -61.7% | -51.4% |
| Utilities | XLU | 5.33% | -55.9% | -69.7% | -65.6% |
| Aerospace & Defense | XAR | 1.62% | -53.9% | -77.8% | -72.2% |
| Biotech | XBI | 2.05% | -46.4% | -53.5% | -42.9% |
| Homebuilder | XHB | 2.93% | -48.2% | -51.6% | -37.2% |
| Retail | XRT | 3.97% | -51.3% | -62.4% | -41.6% |